Image

UICMEW | Evaluation Questionnaire

UICMEW | Evaluation
We greatly value your opinion. Please complete this evaluation and submit it to the registration desk at the conclusion of this activity. Your
responses will be used in future planning of activities and materials.
Please select the conference attended:
I am a:

Upon completion of this activity I am better able to:

Discuss advancements and optimal strategies for bispecific T-cell engagers and novel therapies in Non-Hodgkin Lymphoma (NHL).
Review novel advancements in CAR T-cell therapy for NHL and leukemias.
Explain how to optimize treatment selection in Multiple Myeloma (MM), including the use of minimal residual disease (MRD) in the therapeutic setting.
Review the latest treatment approaches in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).

Upon completion of this activity I am better able to:

Discuss the current and future applications of newly approved targeted therapies across breast cancer sub-types
Identify the side effects of innovative, practice-changing therapies and incorporate them into community practice
Review new diagnostics and treatments in the management of Renal, Urothelial, and Prostate cancers

Upon completion of this activity I am better able to:

Explain the limitations of current registrational studies as they apply to minority populations and FDA guidance for proving this racial disparity (health equity)
Describe the principles of antibody-drug conjugate therapy and current approved indications
Discuss the principles of biological cell engagers/cell therapies and current approved indications
Identify currently approved and emerging diagnostics for early cancer detection and minimal residual disease

Please indicate the extent of your agreement with the following statements:

The faculty for this activity were effective.
The education resources and/or handouts provided to me at the educational activity are useful to my practice.
Overall, was this fair, balanced and free from commercial bias?
Of the patients you will see in the next week, about how many will benefit from the information you learned today?
Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):
Which ONE delivery method do you find the most effective for CME/CE learning?

Please rate the professional practice value of each of the following in terms of improving your practice:

Today's CME event:
Direct to consumer advertising:
Sales representative visits:
Promotional/other non-certified education:
Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):
What motivated you to participate in this activity? (check all that apply)